The clinical implications of anosognosia in Alzheimer's disease.

Moro V, Vianello G, Gambina G, Gobbetto V, Gasparini M, Beccherle M

Open source

DOI
10.1080/14737175.2026.2726416
Published
2026 Sep 6
Container
Expert review of neurotherapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14737175.2026.2726416,
  title = {The clinical implications of anosognosia in Alzheimer's disease.},
  author = {Moro V and Vianello G and Gambina G and Gobbetto V and Gasparini M and Beccherle M},
  year = {2026},
  journal = {Expert review of neurotherapeutics},
  doi = {10.1080/14737175.2026.2726416},
  url = {https://doi.org/10.1080/14737175.2026.2726416}
}

RIS

TY  - JOUR
TI  - The clinical implications of anosognosia in Alzheimer's disease.
AU  - Moro V
AU  - Vianello G
AU  - Gambina G
AU  - Gobbetto V
AU  - Gasparini M
AU  - Beccherle M
PY  - 2026
JO  - Expert review of neurotherapeutics
DO  - 10.1080/14737175.2026.2726416
UR  - https://doi.org/10.1080/14737175.2026.2726416
ER  - 

APA

V, M., G, V., G, G., V, G., M, G., & M, B. (2026). The clinical implications of anosognosia in Alzheimer's disease.. Expert review of neurotherapeutics. https://doi.org/10.1080/14737175.2026.2726416

Source records